News

Evaluation of ex vivo drug combination optimization platform in recurrent high grade astrocytic glioma: An interventional, non-randomized, open-label trial protocol

Dr Toh Tan Boon’s team is excited to share their latest clinical trial protocol in PLOS ONE, “Evaluation of ex vivo drug combination optimization platform in recurrent high grade astrocytic glioma: An interventional, non-randomized, open-label trial protocol”.

Read More: Evaluation of ex vivo drug combination optimization platform in recurrent high grade astrocytic glioma: An interventional, non-randomized, open-label trial protocol – PLOS ONE

view MORE related

News

2024
A/Prof Ngiam Kee Yuan won National Day Award
More Details >
2024
A/Prof Christopher Chen won the Graduate Mentor of the Year (GRAMAY) Award 2024
More Details >
2024
Dexter Thng Kai Hao won Too Joon Chew PhD Prize 2024
More Details >
get in touch and

Contact Us

For inquiries pertaining to our R&D Programs, please contact Khew Si Ying at khewsiying@nus.edu.sg

The Institute for Digital Medicine (WisDM)

  • 28 Medical Drive, #05-COR,
    Singapore 117456

© National University of Singapore. All Rights Reserved.